Sponsored Links
| Medifocus Inc. Announces Institutional Review Board (IRB) Approval For Second USA Site For Its Phase III Pivotal Breast Cancer Treatment Study |
 |
 |
 |
| Medical News - Breast Cancer | |||
|
Medifocus Inc. (OTC:MDFZF.PK) and (TSXV:MFS) is pleased to announce that the Western Institutional Review Board (WIRB) has granted IRB approval to the Comprehensive Breast Center of Coral Springs Florida, a division of 21st Century Oncology to conduct Medifocus' Pivotal Phase III Breast Cancer Treatment Study, under the supervision of Dr. Mary Beth Tomaselli, M.D... Read more: Breast Cancer News From Medical News Today
|